Latest News
Our research at the ESMO Congress 2023
Our researchers from the MRC Clinical Trials Unit at UCL and our collaborators will showcase their latest work on cancer trials at the ESMO Congress 2023.
Having more frequent chemotherapy and bevacizumab treats advanced ovarian cancer more effectively
Results from the ICON8B trial show that combined chemotherapy and bevacizumab treatment is better at preventing ovarian cancer coming back or getting worse when chemotherapy is given weekly rather than every 3 weeks.
New animation: What to expect at a PK study day
A new animated video aimed at study participants explains what happens during a pharmacokinetics (PK) study.
New podcast episode: Optimising treatments with the new MAMS-ROCI design
In the latest Trial Talk episode, we explore the MAMS-ROCI design, a type of multi-arm multi-stage design that can be used to optimise continuous aspects of a treatment.
D3 HIV trial completes recruitment ahead of schedule
The D3 team have successfully completed recruitment of more than 370 children and adolescents living with HIV, ahead of schedule.